GlassScriptPhysician profile
Danielle L Thompson
NPI 1508428921
$9,459.17
in general payments reported to CMS, 2019-2025
51 companies · $1,698 in 2025
The $1,698 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $849 · 2022: $2,977 · 2023: $2,673 · 2024: $1,262 · 2025: $1,698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,633.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,540.00 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,402.95 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $872.96 | 2022-2025 | |
| Exact Sciences Corporation | $569.24 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $538.24 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $454.29 | 2021-2025 | Spiriva Respimat, Jardiance, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $425.76 | 2022-2025 | Entyvio, Trintellix |
| Astrazeneca Pharmaceuticals LP | $332.25 | 2021-2024 | Breztri |
| Amgen INC. | $262.37 | 2021-2024 | Repatha, Otezla |
| Daiichi Sankyo INC. | $224.34 | 2022-2025 | Injectafer |
| Pfizer INC. | $202.63 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $168.85 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $157.23 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Amarin Pharma, INC. | $140.20 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.86 | 2022-2024 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.40 | 2021-2025 | Xifaxan |
| Boston Scientific Corporation | $119.68 | 2025 | Watchman |
| Abbott Laboratories | $113.79 | 2025 | Freestyle Libre 3 |
| Regeneron Healthcare Solutions, INC. | $110.32 | 2024-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $101.85 | 2022-2025 | Eliquis, Camzyos |
| Kowa Pharmaceuticals America, INC. | $101.46 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $87.28 | 2021-2023 | Xarelto |
| Phathom Pharmaceuticals, INC. | $85.08 | 2023-2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $84.68 | 2022-2024 | Rexulti |
| Sanofi-Aventis U.S. LLC | $78.76 | 2022-2025 | |
| Astellas Pharma US INC | $78.45 | 2022-2024 | Veozah |
| Inogen, INC. | $74.40 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Idorsia Pharmaceuticals US INC | $72.48 | 2022-2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $65.61 | 2022-2023 | |
| Gilead Sciences, INC. | $63.82 | 2022 | |
| Madrigal Pharmaceuticals | $63.64 | 2025 | Rezdiffra |
| Axsome Therapeutics, INC. | $57.38 | 2023-2025 | Auvelity, Symbravo |
| Genzyme Corporation | $54.94 | 2024 | |
| Collegium Pharmaceutical, INC. | $54.23 | 2023-2024 | Belbuca, Xtampza |
| Edwards Lifesciences Corporation | $48.73 | 2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Dexcom, INC. | $43.98 | 2022-2025 | Dexcom G6 Transmitter |
| Grifols USA, LLC | $42.39 | 2022-2025 | Prolastin-C Liquid |
| Eisai INC. | $34.13 | 2022 | |
| Shield Therapeutics INC | $33.45 | 2023 | Accrufer |
| Corcept Therapeutics | $29.38 | 2025 | Korlym |
| Vanda Pharmaceuticals INC. | $26.74 | 2023 | Hetlioz |
| Lundbeck LLC | $25.53 | 2023 | Rexulti |
| Jazz Pharmaceuticals INC. | $24.27 | 2022 | |
| Ironwood Pharmaceuticals, INC | $21.56 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $18.02 | 2022 | |
| Seqirus USA INC | $17.15 | 2025 | Fluad, Flucelvax |
| Insulet Corporation | $16.33 | 2025 | Omnipod |
| Sumitomo Pharma America, INC. | $16.09 | 2025 | Gemtesa |
| Hikma Pharmaceuticals USA | $15.45 | 2023 | Ryaltris |
| Alkermes, INC. | $15.30 | 2023 | Vivitrol |
| Biohaven Pharmaceutical Holding Company LTD. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.